Safety, tolerability, and clinical activity of selinexor in combination with pembrolizumab in treatment of metastatic non–small cell lung cancer

Mehmet Altan, Janet Tu, Denái R. Milton, Bulent Yilmaz, Yanyan Tian, Frank V. Fossella, Frank E. Mott, George R. Blumenschein, Bettzy Stephen, Daniel D. Karp, Funda Meric-Bernstam, John V. Heymach, Aung Naing

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Safety, tolerability, and clinical activity of selinexor in combination with pembrolizumab in treatment of metastatic non–small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences